Beam Therapeutics (BEAM) is up 23.4%, or $6.44 to $33.99.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BEAM:
- Beam Therapeutics outlines 2026 strategy and extends runway
- Beam Therapeutics initiated with a Neutral at UBS
- Beam Therapeutics price target raised to $45 from $43 at BofA
- Cathie Wood Wraps Up 2025 with New Biotech Buys — Here’s What It Sold
- Cathie Wood Closes Out 2025 with a Rocket Lab (RKLB) Trim and Fresh Biotech Bets